CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates gene therapy using cell-free DNA to understand patient responses to treatments for inherited and acquired disorders. By analyzing DNA signatures, it aims to identify factors that influence the success of engineered cells in restoring normal physiological functions in patients.
Gene therapy (GT) with integrative vectors has emerged as a revolutionary intervention for the treatment of inherited and acquired disorders.
Despite the great achievements, a major challenge pertains to the heterogeneity of responses that can be obtained in patients.
The success of these applications critically depends on the ability of engineered cells to functionally integrate within the patients’ tissues to re-establish the physiological functions.
Intrinsic features of the cellular drug pro…
OSPEDALE SAN RAFFAELE SRL
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
